Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Gamma-aminobutyric acid type A receptor alpha-1 beta-2 gamma-2 subtype (GABA-A receptor α1β2γ2) is the most abundant inhibitory neurotransmitter receptor in the adult mammalian brain, primarily mediating fast synaptic inhibition (Olsen & Sieghart, 2008). It is a heteropentameric ligand-gated ion channel that facilitates the influx of chloride ions upon activation by GABA, resulting in hyperpolarization of the postsynaptic neuron (Sigel & Steinmann, 2012). This specific subtype is highly concentrated in the cerebral cortex, hippocampus, and cerebellum, where it plays a critical role in regulating neuronal excitability and rhythmic activity (Rudolph & Möhler, 2014). The α1-containing receptors are specifically associated with the sedative, hypnotic, and anticonvulsant effects of benzodiazepines, as well as the amnestic properties of these drugs (Rudolph & Knoflach, 2011). Clinically, this receptor is the primary target for a wide range of CNS depressants, including benzodiazepines, non-benzodiazepine "Z-drugs" like zolpidem, and certain general anesthetics (StatPearls, 2023). Dysfunction or altered expression of this subtype is linked to various neurological disorders such as epilepsy, insomnia, and chronic anxiety (Jacob et al., 2008).
Positive allosteric modulation of the GABA-A receptor, which increases the frequency of chloride channel opening in the presence of GABA, thereby enhancing inhibitory neurotransmission.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-aminobutyric acid type A receptor alpha-1 beta-2 gamma-2 subtype (GABA-A receptor α1β2γ2) (GABA-A receptor α1β2γ2).